News / Events

Recent News View All News

Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL™ Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

January 25, 2021

Abeona Therapeutics Announces Acceptance of Late-Breaker Abstracts Highlighting New Clinical Data for Novel AAV-based Gene Therapies in MPS IIIA and MPS IIIB at WORLDSymposium™

December 21, 2020

View All News

Upcoming Events View IR Calendar

17th Annual WORLDSymposium™

Feb 12, 2021

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up